Gabelli Funds LLC Horizon Therapeutics Public LTD CO Transaction History

Gabelli Funds LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$98.98 - $115.74 $2.13 Million - $2.5 Million	21,566 Added 5.49%	414,455 $47.9 Million
Q2 2023 Aug 10, 2023	SELL	$96.34 - $112.38 $6.78 Million - $7.91 Million	-70,405 Reduced 15.2%	392,889 $40.4 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $25.9 Million - $27.4 Million	241,294 Added 108.69%	463,294 $50.6 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $13.9 Million - $25.3 Million	222,000 New	222,000 $25.3 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.